255 related articles for article (PubMed ID: 23432979)
21. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
Liu L; Lu W; Ma Z; Li Z
Int J Mol Med; 2012 May; 29(5):815-22. PubMed ID: 22367596
[TBL] [Abstract][Full Text] [Related]
22. Role of the chemokine receptor CXCR2 in bleomycin-induced pulmonary inflammation and fibrosis.
Russo RC; Guabiraba R; Garcia CC; Barcelos LS; Roffê E; Souza AL; Amaral FA; Cisalpino D; Cassali GD; Doni A; Bertini R; Teixeira MM
Am J Respir Cell Mol Biol; 2009 Apr; 40(4):410-21. PubMed ID: 18836137
[TBL] [Abstract][Full Text] [Related]
23. Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma.
Hirata H; Arima M; Fukushima Y; Honda K; Sugiyama K; Tokuhisa T; Fukuda T
Clin Exp Allergy; 2011 Aug; 41(8):1133-42. PubMed ID: 21429049
[TBL] [Abstract][Full Text] [Related]
24. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
25. [The effect of murine interferon-gamma transgene expression on bleomycin-induced pulmonary fibrosis in mice].
Tian GZ; Gao ZC; Xu Y; Gai J; Dong JQ; He QY
Zhonghua Jie He He Hu Xi Za Zhi; 2003 May; 26(5):290-3. PubMed ID: 12892616
[TBL] [Abstract][Full Text] [Related]
26. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
27. Early granulocyte-macrophage colony-stimulating factor expression by alveolar inflammatory cells during bleomycin-induced rat lung fibrosis.
Andreutti D; Gabbiani G; Neuville P
Lab Invest; 1998 Dec; 78(12):1493-502. PubMed ID: 9881949
[TBL] [Abstract][Full Text] [Related]
28. Role of eukaryotic translation initiation factor 3a in bleomycin-induced pulmonary fibrosis.
Li XW; Wu YH; Li XH; Li D; Du J; Hu CP; Li YJ
Eur J Pharmacol; 2015 Feb; 749():89-97. PubMed ID: 25592322
[TBL] [Abstract][Full Text] [Related]
29. Deficiency of developmental endothelial locus-1 (Del-1) aggravates bleomycin-induced pulmonary fibrosis in mice.
Kang YY; Kim DY; Lee SH; Choi EY
Biochem Biophys Res Commun; 2014 Mar; 445(2):369-74. PubMed ID: 24525119
[TBL] [Abstract][Full Text] [Related]
30. Interactions between leukotriene C4 and interleukin 13 signaling pathways in a mouse model of airway disease.
Chavez J; Young HW; Corry DB; Lieberman MW
Arch Pathol Lab Med; 2006 Apr; 130(4):440-6. PubMed ID: 16594735
[TBL] [Abstract][Full Text] [Related]
31. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Okamoto Y; Kikkawa H; Asano S; Kinoshita M
J Clin Pathol; 2007 Mar; 60(3):283-9. PubMed ID: 16751304
[TBL] [Abstract][Full Text] [Related]
32. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
33. Protection from pulmonary fibrosis in leukotriene-deficient mice.
Peters-Golden M; Bailie M; Marshall T; Wilke C; Phan SH; Toews GB; Moore BB
Am J Respir Crit Care Med; 2002 Jan; 165(2):229-35. PubMed ID: 11790660
[TBL] [Abstract][Full Text] [Related]
34. The D prostanoid receptor agonist BW245C [(4S)-(3-[(3R,S)-3-cyclohexyl-3-hydroxypropyl]-2,5-dioxo)-4-imidazolidineheptanoic acid] inhibits fibroblast proliferation and bleomycin-induced lung fibrosis in mice.
van den Brule S; Wallemme L; Uwambayinema F; Huaux F; Lison D
J Pharmacol Exp Ther; 2010 Nov; 335(2):472-9. PubMed ID: 20719937
[TBL] [Abstract][Full Text] [Related]
35. Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin.
Azuma A; Li YJ; Abe S; Usuki J; Matsuda K; Henmi S; Miyauchi Y; Ueda K; Izawa A; Sone S; Hashimoto S; Kudoh S
Am J Respir Cell Mol Biol; 2005 Feb; 32(2):93-8. PubMed ID: 15557019
[TBL] [Abstract][Full Text] [Related]
36. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
37. E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis.
Horikawa M; Fujimoto M; Hasegawa M; Matsushita T; Hamaguchi Y; Kawasuji A; Matsushita Y; Fujita T; Ogawa F; Takehara K; Steeber DA; Sato S
Am J Pathol; 2006 Sep; 169(3):740-9. PubMed ID: 16936251
[TBL] [Abstract][Full Text] [Related]
38. Prostaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.
Nakanishi T; Hasegawa Y; Mimura R; Wakayama T; Uetoko Y; Komori H; Akanuma S; Hosoya K; Tamai I
PLoS One; 2015; 10(4):e0123895. PubMed ID: 25923111
[TBL] [Abstract][Full Text] [Related]
39. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis.
Gurujeyalakshmi G; Hollinger MA; Giri SN
Am J Respir Cell Mol Biol; 1998 Mar; 18(3):334-42. PubMed ID: 9490651
[TBL] [Abstract][Full Text] [Related]
40. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
